Osaic Holdings
AKBA icon

Osaic Holdings’s Akebia Therapeutics AKBA Stock Holding History

Osaic Holdings’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.7K Sell
69,926
-4,751
-6% -$5.66K ﹤0.01% 5127
2026
Q1 		$104K Buy
74,677
+9,454
+14% +$13K ﹤0.01% 4661
2025
Q4 		$105K Sell
65,223
-1,056
-2% -$2.21K ﹤0.01% 4663
2025
Q3 		$208K Buy
66,279
+51,505
+349% +$171K ﹤0.01% 4178
2025
Q2 		$53.8K Buy
14,774
+774
+6% +$2.13K ﹤0.01% 4997
2025
Q1 		$26.9K Buy
14,000
+7,550
+117% +$15.4K ﹤0.01% 5149
2024
Q4 		$12.3K Buy
6,450
+2,000
+45% +$3.47K ﹤0.01% 5652
2024
Q3 		$5.87K Sell
4,450
-103
-2% -$138 ﹤0.01% 6121
2024
Q2 		$4.64K Buy
4,553
+2,814
+162% +$3.48K ﹤0.01% 6218
2024
Q1 		$3.18K Buy
1,739
+1,000
+135% +$1.6K ﹤0.01% 6293
2023
Q4 		$916 Hold
739
– – ﹤0.01% 6782
2023
Q3 		$842 Hold
739
– – ﹤0.01% 6872
2023
Q2 		$676 Hold
739
– – ﹤0.01% 6981
2023
Q1 		$414 Hold
739
– – ﹤0.01% 7166
2022
Q4 		$0 Sell
739
-224
-23% -$70 ﹤0.01% 7150
2022
Q3 		$0 Hold
963
– – ﹤0.01% 7228
2022
Q2 		$0 Hold
963
– – ﹤0.01% 7299
2022
Q1 		$1K Hold
963
– – ﹤0.01% 6978
2021
Q4 		$3K Hold
963
– – ﹤0.01% 6841
2021
Q3 		$3K Sell
963
-12,093
-93% -$34.5K ﹤0.01% 6706
2021
Q2 		$49K Hold
13,056
– – ﹤0.01% 5050
2021
Q1 		$45K Buy
13,056
+100
+0.8% +$360 ﹤0.01% 4946
2020
Q4 		$36K Buy
12,956
+11,294
+680% +$33K ﹤0.01% 4780
2020
Q3 		$4K Sell
1,662
-2,247
-57% -$19.7K ﹤0.01% 5615
2020
Q2 		$53K Sell
3,909
-7,970
-67% -$82.5K ﹤0.01% 4145
2020
Q1 		$90K Buy
+11,879
New +$92.4K ﹤0.01% 3544

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Osaic Holdings's AKBA Position: Q2 2026 in Review

Osaic Holdings reduced its Akebia Therapeutics (AKBA) stake by 6.4% in Q2 2026, selling an estimated $5.66K and leaving 69,926 shares worth $79.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5127.

Osaic Holdings first reported a position in AKBA in Q1 2020 and has held it in 26 quarters since. The position peaked at $208K in Q3 2025. 171 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • Osaic Holdings held 69,926 shares of Akebia Therapeutics worth $79.7K as of Q2 2026.
  • Osaic Holdings sold 4,751 Akebia Therapeutics shares in Q2 2026, an estimated $5.66K.
  • Akebia Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5127 holding.
  • Osaic Holdings first reported a position in Akebia Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Akebia Therapeutics position peaked at $208K in Q3 2025.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.